WILLIAMS AND JENSEN, PLLC for ELI LILLY & COMPANY
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
International and domestic tax issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | Sch. C, Treasury; Associate Staff, House Rules Committee; LD, Rep. Scott McInnis |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
| DANIEL ZIEGLER | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn |
Health Issues HCR
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
| MELINDA M MAXFIELD | — |
| CHRISTOPHER E. WILCOX | Regional Staff Asst & Staff Asst, Senator Moynihan; LA, Leg Counsel, LD & Counsel, Rep Arcuri; LD & Counsel, Rep Demings |
| DANIEL ZIEGLER | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn |
Medicare/Medicaid MMM
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
| DANIEL ZIEGLER | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn |
Budget/Appropriations BUD
Accelerated approval pathway; support for Alzheimers diagnostics; FY 2024 Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | Sch. C, Treasury; Associate Staff, House Rules Committee; LD, Rep. Scott McInnis |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| CHRISTOPHER E. WILCOX | Regional Staff Asst & Staff Asst, Sen. Moynihan; LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings |
| DANIEL ZIEGLER | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn |
Trade (domestic/foreign) TRD
Issues related to pharmaceutical manufacturing and development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
| CHRISTOPHER E. WILCOX | Regional Staff Asst & Staff Asst, Sen. Moynihan; LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings |
| DANIEL ZIEGLER | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn |
Defense DEF
Issues related to pharmaceutical manufacturing and development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
| CHRISTOPHER E. WILCOX | Regional Staff Asst & Staff Asst, Sen. Moynihan; LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings |
| DANIEL ZIEGLER | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.